Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

PHATPHAT
Showing 8 of 27 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in PHATHOM PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.3M shares of PHAT (PHATHOM PHARMACEUTICALS INC), worth $14.3M as of 2026-Q2. The position was decreased (-0.9% shares). PHAT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$14.3M

Current Shares

1.3M

Total Value Change

-$1.3M

Total Shares Change

+452,769

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-0.9%
$14.3M0.0%$10.85
0
2026-Q1
Increased
1.3M
+23.7%
$14.8M0.0%$11.05
34
2025-Q4
Decreased
1.1M
-1.4%
$17.8M0.0%$16.92
0
2025-Q3
Increased
1.1M
+1.8%
$12.8M0.0%$11.33
28
2025-Q2
Increased
1.1M
+5.3%
$10.3M0.0%$9.74
29
2025-Q1
Decreased
1M
-0.2%
$6.4M0.0%$6.60
0
2024-Q4
Increased
1M
+18.0%
$8.3M0.0%$8.00
32
2024-Q3
Increased
862,918
+7.1%
$15.6M0.0%$17.52
30

Other major holders of PHAT: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used